Prof. Carl D. Regillo, MD, presented clinical data from the Phase 1b trial evaluating Breye Therapeutics’ lead candidate, danegaptide, in 24 patients with non-proliferative diabetic retinopathy (NPDR) ...
The public release improves audio, speech, debugging, and developer experience. Additionally, a more cost-effective mini variant can be used.
Money Talks News on MSN
Work-from-home jobs with 6-figure salaries
You might be surprised by some of the jobs you can do from home.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results